Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment  Lies Clerx, Ineke A. van.

Slides:



Advertisements
Similar presentations
MRI as a Potential Surrogate Marker in the ADCS MCI Trial
Advertisements

Structural and Functional Neuroimaging in the Diagnosis of Dementia John M. Ringman, M.D. Assistant Professor UCLA Department of Neurology.
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Volume 3, Issue 4, Pages (November 2017)
APOE and aging-related cognitive change in a longitudinal cohort of men  Ville Rantalainen, Jari Lahti, Markus Henriksson, Eero Kajantie, Pentti Tienari,
The C9ORF72 expansion does not affect the phenotype in Nasu-Hakola disease with the DAP12 mutation  Eino Solje, Päivi Hartikainen, Miko Valori, Ritva.
Diffusion tensor imaging and Tract-Based Spatial Statistics in Alzheimer's disease and mild cognitive impairment  Yawu Liu, Gabriela Spulber, Kimmo K.
Manuela Tondelli, Gordon K. Wilcock, Paolo Nichelli, Celeste A
Hilkka Liedes, Jyrki Lötjönen, Gerald P. Novak, Mark Forrest Gordon 
Lars A. Ewell, Christopher J. Watchman, Kurt Wharton 
Volume 3, Issue 1, Pages 1-9 (January 2017)
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease  Azadeh Karami, Helga Eyjolfsdottir, Swetha.
Cognitive Interventions in Mild Alzheimer's Disease: A Therapy-Evaluation Study on the Interaction of Medication and Cognitive Treatment Dement Geriatr.
Parkinsonism & Related Disorders
Copyright © 2000 American Medical Association. All rights reserved.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
The differential diagnosis of amnestic mild cognitive impairment and Alzheimer's disease dementia by hippocampal volume measurement with MR in a chinese.
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints  Argonde C. van Harten, Pieter Jelle Visser,
Alzheimer's biomarkers in daily practice (ABIDE) project: Rationale and design  Arno de Wilde, Ingrid S. van Maurik, Marleen Kunneman, Femke Bouwman, Marissa.
24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled.
A NOVEL NEUROIMAGING APPROACH TO CAPTURE COGNITIVE RESERVE
Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire  Roos J.
Polygenic score prediction captures nearly all common genetic risk for Alzheimer's disease  Valentina Escott-Price, Maryam Shoai, Richard Pither, Julie.
Association between MAPT haplotype and memory function in patients with Parkinson's disease and healthy aging individuals  Sophie E. Winder-Rhodes, Adam.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Alzheimer’s disease core biomarkers and prediction of dementia in MCI: The effect of age at onset  Anna Caroli, Samantha Galluzzi, Clarissa Ferrari, Annapaola.
An amylin analog used as a challenge test for Alzheimer's disease
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment  Sanna-Kaisa Herukka,
Remko Kockelkoren, Pushpa M Jairam, John T. Murchison, Thomas P. A
Colin Groot, Chris W. J. van der Weijden, Wiesje M
Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline  Sander C.J.
Volume 2, Issue 1, Pages (January 2016)
Ben Sherwood, Andrew Xiao-Hua Zhou, Sandra Weintraub, Lan Wang 
Early diagnosis of mild cognitive impairment and Alzheimer's disease based on salivary lactoferrin  Eva Carro, Fernando Bartolomé, Félix Bermejo-Pareja,
Lesion Mapping of Cognitive Abilities Linked to Intelligence
How to Characterize the Function of a Brain Region
Early Dementia Distinguishing AD From MCI
Volume 16, Issue 12, Pages (December 2017)
Panayiotopoulos syndrome
Volume 81, Issue 6, Pages (March 2014)
A Network Diffusion Model of Disease Progression in Dementia
Volume 16, Issue 8, Pages (August 2017)
Fusion of deep learning models of MRI scans, Mini–Mental State Examination, and logical memory test enhances diagnosis of mild cognitive impairment  Shangran.
Michael Ewers, Reisa A. Sperling, William E. Klunk, Michael W
Benjamin Cretin, Nathalie Philippi 
Glycemia and Cognitive Function in Metabolic Syndrome and Coronary Heart Disease  Radhika Avadhani, MS, Kristen Fowler, RN, Corinne Barbato, BS, Sherine.
Hemispheric Cerebral Edema
Visual System: Prostriata — A Visual Area Off the Beaten Path
Right atrial area and right ventricular outflow tract akinetic length predict sustained tachyarrhythmia in repaired tetralogy of Fallot  Beatrice Bonello,
Volume 73, Issue 4, Pages (February 2012)
A Risk Prediction Model for Invasive Fungal Disease in Critically Ill Patients in the Intensive Care Unit  Fangyi Li, Minggen Zhou, Zijun Zou, Weichao.
Biomarker Modeling of Alzheimer’s Disease
Tharick A. Pascoal, Sulantha Mathotaarachchi, Monica Shin, Andrea L
Volume 14, Issue 12, Pages (December 2017)
Volume 17, Issue 2, Pages (February 2018)
Personalized Medicine in Psychiatry
Volume 81, Issue 6, Pages (March 2014)
The Reply The American Journal of Medicine
Sunku H Guptha, Eric Holroyd, Gordon Campbell
Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity  Severine Vermeire, Stefan Schreiber,
Systematic reviews and meta-analyses of diagnostic test accuracy
Figure 2 A case of early-onset PSD
In the Literature: Cognitive Impairment in Hemodialysis Patients
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients  Eric R. Siemers, Karen L. Sundell, Christopher Carlson, Michael Case,
GREY MATTER CONNECTIVITY IS ASSOCIATED WITH CLINICAL PROGRESSION IN NON-DEMENTED, AMYLOID POSITIVE PATIENTS  Betty M. Tijms, Mara ten Kate, Sander C.J.
Volume 16, Issue 8, Pages (August 2017)
Figure 1 NMF in ADD patients and classification of prodromal Alzheimer’s disease participants. Grey matter ... Figure 1 NMF in ADD patients and classification.
Fig. 1. ROC curve for K-IADL to diagnose dementia or MCI
ROC curve for the TYM-MCI, ACE-R and MMSE in the separation of patients with aMCI/AD from those with SMC. ACE-R, Addenbrooke’s Cognitive Examinations;
Presentation transcript:

Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment  Lies Clerx, Ineke A. van Rossum, Leah Burns, Dirk L. Knol, Philip Scheltens, Frans Verhey, Pauline Aalten, Pablo Lapuerta, Laura van de Pol, Ronald van Schijndel, Remko de Jong, Frederik Barkhof, Robin Wolz, Daniel Rueckert, Martina Bocchetta, Magdalini Tsolaki, Flavio Nobili, Lars-Olaf Wahlund, Lennart Minthon, Lutz Frölich, Harald Hampel, Hilkka Soininen, Pieter Jelle Visser  Neurobiology of Aging  Volume 34, Issue 8, Pages 2003-2013 (August 2013) DOI: 10.1016/j.neurobiolaging.2013.02.002 Copyright © 2013 Elsevier Inc. Terms and Conditions

Fig. 1 AUC of a ROC-curve for MRI measurements for (A) total sample, (B) DESCRIPA cohort and (C) VUmc cohort. All volumetric measurements are corrected for intracranial volume. Abbreviations: AUC, area under the curve; LEAP, learning embeddings for atlas propagation; MRI, magnetic resonance imaging; MTA, medial temporal lobe atrophy; ROC, receiver operating characteristics. Neurobiology of Aging 2013 34, 2003-2013DOI: (10.1016/j.neurobiolaging.2013.02.002) Copyright © 2013 Elsevier Inc. Terms and Conditions

Fig. 2 Spline analyses showing AD-free survival after 2 years as function of MRI measurement in the total cohort for (A) manual hippocampal volume, (B) LEAP hippocampal volume, (C) MTA-score, and (D) lateral ventricle volume. Red line indicates cut point that maximized the Youden index. All volumetric measurements are corrected for intracranial volume. Abbreviations: AD, Alzheimer's disease; LEAP, learning embeddings for atlas propagation; MRI, magnetic resonance imaging; MTA, medial temporal lobe atrophy; MTA-score, qualitative ratings of medial temporal lobe atrophy. Neurobiology of Aging 2013 34, 2003-2013DOI: (10.1016/j.neurobiolaging.2013.02.002) Copyright © 2013 Elsevier Inc. Terms and Conditions

Fig. 3 Slope analyses showing annual cognitive decline on (A) the MMSE and (B) a cognitive composite score as predicted by baseline medial temporal lobe measurements. Abnormal MRI values at baseline were defined as manual hippocampal volume <7559 mm3, LEAP hippocampal volume <5374 mm3, MTA-score ≥3, and lateral ventricle volume ≥58491 mm3. The solid lines indicate the subjects with normal values. The dotted lines indicates subjects with abnormal values. All volumetric measurements are corrected for intracranial volume. The cognitive composite score = average z-score of learning or delayed recall of a word list learning test or equivalent memory test, the Trail Making Test part A, Trail Making Test part B, verbal fluency, Rey figure copy test, or an equivalent test. Abbreviations: LATVEN, lateral ventricle volume; LEAP, learning embeddings for atlas propagation; MAN, manual hippocampal volume; MMSE, Mini Mental State Examination; MRI, magnetic resonance imaging; MTA, medial temporal lobe atrophy score; MTA-score, qualitative ratings of medial temporal lobe atrophy. Neurobiology of Aging 2013 34, 2003-2013DOI: (10.1016/j.neurobiolaging.2013.02.002) Copyright © 2013 Elsevier Inc. Terms and Conditions